Decreases in serum apolipoprotein C-III concentration in cows with ethionine-induced fatty liver.
To monitor the serum concentration of apolipoprotein C-III (apoC-III), one of the functional apoproteins in lipid metabolism, in cows with ethionine-induced fatty liver, and to investigate the association of apoC-III with liver triglyceride (TG) content and serum biochemical variables, seven nonpregnant nonlactating Holstein cows (3 to 6 years old) were used. Five cows were treated with ethionine, an analogue of methionine, (days 0, 7 and 14). The remaining two controls received saline as the vehicle. Liver TG contents in the treated cows were increased markedly whenever administered, and significant increases were observed at days 14 (666.4%, 85.3 mg/g) and 21 (675.0%, 86.4 mg/g) compared with day 0. In controls, no significant changes in liver TG content and serum biochemical variables were observed during this experiment. The serum apoC-III concentration in the treated cows was decreased drastically after the first administration and fell to the lowest value at day 10 (76.2 microg/ml, 32% of day 0). The apoC-III was significantly (p<0.05) correlated with non-esterified fatty acids (r= -0.526), gamma-glutamyl transpeptidase (r= -0.407), total bilirubin (r= -0.464), positively with apolipoprotein B-100 (apoB-100, r=0.601) and cholesterol ester (r=0.449). Although apoB-100 concentrations were also reduced by the administrations, the concentrations tended to recover smoothly toward the next administration. The distinct difference in change between apoC-III and apoB-100 suggests that apoC-III may be regulated by other pathways, in addition to inhibiting the synthesis of apoproteins by ethionine.
Department of Veterinary Internal Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, Japan.
Atsushi
A
Nitanai
Norio
N
Katoh
Shin
S
Oikawa
Masakazu
M
Saitoh
Masaomi
M
Hamada
Akihito
A
Kutsuzawa
Tharwat
T
Mohamed
Eiji
E
Uchida
Daiji
D
Endoh
Takashi
T
Kurosawa
Hiroshi
H
Sato
D000704:Analysis of Variance; D000818:Animals; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000097:blood*; D001774:Blood Chemical Analysis / Q000662:veterinary; D015153:Blotting, Western / Q000662:veterinary; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood*; D004591:Electrophoresis, Polyacrylamide Gel / Q000662:veterinary; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005001:Ethionine / Q000633:toxicity; D005234:Fatty Liver / Q000097:blood / Q000139:chemically induced / Q000662:veterinary*; D005260:Female; D008099:Liver / Q000378:metabolism; D013997:Time Factors; D014280:Triglycerides / Q000378:metabolism
D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D014280:Triglycerides; D005001:Ethionine